David Tsao
Person ● Covered in 0 stories + Follow ✴ AI Graph Request update
David Tsao, PhD, is the co-founder and CTO of BillionToOne. BillionToOne, founded in 2016, develops prenatal and oncology liquid biopsy tests, including prenatal screening from a single maternal blood draw and pan-cancer tests for therapy selection and response monitoring. Public company and Y Combinator profiles list Tsao as a co-founder and technical leader of the company. He is known for co-founding BillionToOne and helping lead its technology work in prenatal and oncology testing.
Updated 8 September 2026
Public sources: billiontoone.com ycombinator.com
Why this page exists, and how to correct or remove it
This profile is assembled automatically because David Tsao appears in coverage we index or holds a role listed publicly by their organisation. It uses only public sources — company and organisation pages, news articles, Wikipedia, and public professional listings — and the biography, if any, is written by AI from those sources and cited above.
We hold it to report on the AI industry, under the legitimate interest of journalistic reporting. You can ask us to correct it, restrict it, or take it down, and you can object at any time — no account needed, no reason required.
Claim or correct this profile Request removal How we handle personal data